Progress and unmet needs in understanding fundamental mechanisms of autoimmunity.

Antigenic mimicry Bystander activation Complement Epitope spreading Infection Microbiome Non-coding RNA Personalized medicine T cell aging Trained immunity X chromosome

Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
May 2023
Historique:
received: 14 01 2023
accepted: 14 01 2023
medline: 19 6 2023
pubmed: 1 2 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

The rising incidence of autoimmune diseases is straining the healthcare system's capacity to care for patients with autoimmunity. To further compound this growing crisis, this rise occurs at a time when virulent infectious diseases exacerbate pre-existing conditions. Despite some novel targeted therapies introduced over the preceding decades, current treatment strategies must often fall back on non-specific immunosuppression, inflicting its own toll on patient morbidity. To improve patient care, we must re-double our efforts to understand and target the fundamental mechanisms of autoimmune disease initiation and progression. Technologic innovations have recently accelerated our ability to discover key components of the processes leading to loss of tolerance and propagation of self-tissue damage in autoimmune conditions. The special issue "Cellular and Molecular Mechanisms of Autoimmunity" highlights many of these findings through primary research and review articles which detail advances in genetics, molecular processes, cellular functions, and host-pathogen interactions. Discussion of topics ranging from non-coding RNA and the complement cascade to T-cell aging and the microbiome uncovers exciting avenues for basic and clinical investigation. Importantly, the issue seeks to focus attention on both established and emerging mechanisms of autoimmunity to ultimately help improve the specificity, safety, and efficacy of treatments for this group of challenging immune disorders.

Identifiants

pubmed: 36720662
pii: S0896-8411(23)00008-2
doi: 10.1016/j.jaut.2023.102999
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102999

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Auteurs

Joshua A Reynolds (JA)

Department of Microbiology and Immunology and the Division of Rheumatology, Albert Einstein College of Medicine, New York, USA; Department of Neuroscience, Albert Einstein College of Medicine, New York, USA.

Chaim Putterman (C)

Department of Microbiology and Immunology and the Division of Rheumatology, Albert Einstein College of Medicine, New York, USA; Azrieli Faculty of Medicine of Bar-Ilan University, Safed, Israel; Galilee Research Institute, Nahariya, Israel. Electronic address: chaim.putterman@biu.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH